High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival

Katharine K. Brieger, Minh Tung Phung, Bhramar Mukherjee, Kelly M. Bakulski, Hoda Anton-Culver, Elisa V. Bandera, David D.L. Bowtell, Daniel W. Cramer, Anna DeFazio, Jennifer A. Doherty, Sian Fereday, Renée Turzanski Fortner, Aleksandra Gentry-Maharaj, Ellen L. Goode, Marc T. Goodman, Holly R. Harris, Keitaro Matsuo, Usha Menon, Francesmary Modugno, Kirsten B. Moysich, Bo Qin, Susan J. Ramus, Harvey A. Risch, Mary Anne Rossing, Joellen M. Schildkraut, Britton Trabert, Robert A. Vierkant, Stacey J. Winham, Nicolas Wentzensen, Anna H. Wu, Argyrios Ziogas, Lilah Khoja, Kathleen R. Cho, Karen McLean, Jean Richardson, Bronwyn Grout, Anne Chase, Cindy McKinnon Deurloo, Kunle Odunsi, Brad H. Nelson, James D. Brenton, Kathryn L. Terry, Paul D.P. Pharoah, Andrew Berchuck, Gillian E. Hanley, Penelope M. Webb, Malcolm C. Pike and Celeste Leigh Pearce for the Ovarian Cancer Association Consortium

Cancer Epidemiol Biomarkers Prev February 1 2022 (31) (2) 443-452; DOI: 10.1158/1055-9965.EPI-21-0977